Biome Australia
Biome Australia focuses on the licensing, development, and marketing of complementary medicines, including nutraceuticals and live biotherapeutics. The company operates within the household and personal products industry, aiming to provide innovative health solutions. Biome Australia distributes their products through pharmacies and health food stores.
Short position
Biome Australia (ASX:BIO) has 0.01% of its shares on issue reported as short positions as of 5 Oct 2026, or about 28,480 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 0.26% in January 2025. BIO is classified in the Household & Personal Products industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4Biome Australia (BIO) financials
Results, ratios and statements
Latest result
Year to 30 Jun 2026 (FY26) vs FY25, figures in AUD, the reporting currency · Company filing, 22 Sep 2026
- Revenue
- $23.9MF (source: Company filing (extracted))vs $18.4MM (source: ASX (Markit)) (FY25)
- Company filing (extracted), as at 6 Oct 2026
- NPAT
- n/avs $214.7KM (source: ASX (Markit)) (FY25)
- EPS (basic)
- n/avs $0.001 (FY25)
- Rev YoY
- +29.8%FYF (source: Company filing (extracted))
- EPS YoY
- n/mTTM
- Company filing (extracted)
- ASX (Markit)
Summary of Annual Report, 22 Sep 2026
Biome Australia's FY26 revenue grew 30% to $23.9 million, with net profit of $3.6 million (including a $2.4m tax benefit; underlying $1.2m) and EBITDA up 115% to $2.0 million. No dividend was declared. The company targets at least $75 million in cumulative sales revenue across FY25–FY27, with $42.3 million achieved in the first two years, and expects onshore manufacturing to improve margins from FY27.
Automated summary of the filing; the filing itself is the record.
Key ratios
12 months to 30 Jun 2026 (TTM); no balance sheet aligned with this period; prices to 9 Oct 2026
- Gross margin
- 62.5%
- Operating margin
- 2.4%
- Net margin
- 15.1%
- FCF margin
- 4.8%
- ROE
- n/a
- ROA
- n/a
- FCF conversion
- 0.32×
- Net debt (excl. leases)
- n/a
- Net debt / EBITDA
- n/a
- Current ratio
- n/a
- Interest cover
- 4.2×
- Cash dividends paid / net profit
- n/a
- Market cap
- n/a (no share count we can vouch for)
- P/E
- 25.5×
- P/B
- n/a (no share count we can vouch for)
Ratios use the reporting currency (AUD); market cap is in AUD. Source: Yahoo Finance, as at 29 Sep 2026.
Financial statements
Figures in AUD, the reporting currency; Yahoo Finance unless marked
| Line item | FY26 | FY25 | FY24 | FY23 |
|---|---|---|---|---|
| Revenue | $23.9MF (source: Company filing (extracted)) | $18.4MM (source: ASX (Markit)) | $13.0M | $7.2M |
| Gross profit | n/a | n/a | $7.9M | $4.3M |
| Operating income | n/a | n/a | −$1.9M | −$3.4M |
| EBITDA | n/a | n/a | −$1.3M | −$2.8M |
| EBIT | n/a | n/a | −$1.5M | −$3.0M |
| Interest expense | n/a | n/a | $149.6K | $93.7K |
| Pretax income | n/a | n/a | −$1.7M | −$3.1M |
| Tax | n/a | n/a | $0 | $0 |
| NPAT | n/a | $214.7KM (source: ASX (Markit)) | −$1.7M | −$3.1M |
| Net interest income | n/a | n/a | −$101.1K | −$95.5K |
| EPS basic | n/a | $0.001 | −$0.008 | −$0.015 |
| EPS diluted | n/a | $0.001 | −$0.008 | −$0.015 |
| Shares | n/a | n/a | 215.1M | 201.8M |
- Company filing (extracted)
- ASX (Markit)
Financial reports
The company's own filings, newest first
- Annual ReportAnnual Report22 Sep 2026via asx_announcements
Figures above come from this filing
- Preliminary Final ReportAnnual Results26 Aug 2026via asx_announcements
- Revised Appendix 4C Quarterly Cash Flow ReportQuarterly Report28 Apr 2026via asx_announcements
- Appendix 4D & Half Yearly ReportHalf Year Results23 Feb 2026via asx_announcements
- Biome Half Year Results and WebinarHalf Year Results18 Feb 2026via asx_announcements
- Annual ReportAnnual Report30 Sep 2025via asx_announcements
- Preliminary Final ReportAnnual Results27 Aug 2025via asx_announcements
- Register for Half Year Investor WebinarHalf Year Results3 Mar 2025via asx_announcements
- Appendix 4D & Half Yearly ReportHalf Year Results18 Feb 2025via asx_announcements
- Annual ReportAnnual Report25 Sep 2024via asx_announcements
Showing 10 of 13 reports